Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer

MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines

(2014) P. J. Holst et al.   JOURNAL OF IMMUNOLOGY

Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications

(2009) C. H. Chung et al.   CLINICAL CANCER RESEARCH

Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice

(2009) M. Grujic et al.   JOURNAL OF GENERAL VIROLOGY

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

(2008) Chien-Fu Hung et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses

(2008) D Kim et al.   GENE THERAPY

Immunotherapy for head and neck cancer

(2008) Annie A. Wu et al.   JOURNAL OF BIOMEDICAL SCIENCE